Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Oxytocin for PPH Prevention After Induction
NCT02983591Completed
- Sponsor
- Makassed General Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Makassed General Hospital. Primary endpoint: Hemoglobin level. Started Nov 2016; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02983591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983591.